IC-KDA2025 & ASAD 2025

Submission Guide

Submission Guidelines

IC-KDA & ASAD 2025 Organizing Committee cordially invites you to submit abstracts. Submitters are asked to choose their preferred presentation type and abstract categories when using the submission system. Before making your selection, please scan the entire list for the most appropriate abstract category.
The Scientific committee will review the submitted abstracts, and those accepted will be presented either as Oral Presentations.

Please read the guidelines carefully before submitting your abstract.

Abstract Submission

Important Dates

Deadline for Abstract Submission February 28(Fri), 2025

Abstract Acceptance Notification March 14(Fri), 2025

Step for Submission

Step 1

Sign-up and Login
If you are already signed-up on this website, you can use the account for your abstract submission.
Step 2

Submit your abstract
Fill out the author and abstract information and click the “Save and Next” button.
Step 3

Confirmation Letter
After submission, a confirmation letter will be sent to you via e-mail.
Step 4

My Page
You can review and modify your submitted abstracts on “MY PAGE” until the submission deadline.
Step 5

Acceptance Notification
An acceptance notification will be sent to you via e-mail.

Abstract Topics & Subtopics

Abstract Category
No.	Topics	Subtopics
1	Basic Science and Pathogenesis	Genetics
		Human Neuropathology
		Molecular and Cell Biology
2	Biomarkers	Neuroimaging
		Non-Neuroimaging(Plasma/Serum, etc.)
		Multi-Modal Comparisons
		Prognostic Utility
3	Clinical Manifestations	Clinical Aspects of Neuropsychiatric/Behavioral and Psychological Symptoms
3	Clinical Manifestations	Behavioral Neurology
4	Neuropsychology	Computerized Neuropsychological Assessment
		Early Detection of Cognitive Decline with Neuropsychological Tests
		Neuropsychological Correlates of Physiologic Markers of Cognitive Decline/Dementia
5	Dementia Care	Psychosocial Factors
		Environmental Design
		Managing Dementia-related Behaviors
6	Pharmacological & Non-pharmacological Treatment	Anti-amyloid
		Anti-tau
		Cognitive Enhancement
		Nonpharmacological Interventions
7	Risk Factors, Public Health and Epidemiology	Epidemiology
		Prevention
		Health Service

Submission Guidelines

Submission: All abstracts must be submitted online via the Conference website by February 28, 2025, 11:59pm KST.
Abstracts submitted by fax, email, or post will not be accepted.
Please do not submit multiple copies of the same abstract.
Language: All abstracts must be written and presented in clear English.
Length: Maximum 300 words. *Spaces are not included in the count.
Modification: You can make changes by going to [My Page] before the abstract submission deadline.
Abstract Submission Confirmation: Official letter will be sent to the registrant via email and posted at [My Page].
Oral presentation applicants who are not selected will be redirected to the poster presentation.

Preparing Your Abstract for Submission

The abstract should be as informative as possible and include the following details.

Objectives: background and specific objective of the study
Methods: description of methods used
Results: summary of results obtained
Conclusions: conclusions reached

Confirmation of Receipt and Notification of Decision

All submitted abstracts will be reviewed by the Academic Committee.
After submitting your abstract, you will receive an email confirmation that your abstract has been received.
Please contact the Secretariat if you submitted an abstract and do not receive an email confirmation.
Notification regarding the status of your abstract will be sent out after March 14(Fri), 2025.

Abstract Withdrawal

If you have to withdraw an abstract, please inform the secretariat via e-mail ickda.official@gmail.com.
If the author of an accepted abstract does not register by March 15(Sat), 2025, 11:59pm(KST), the abstract will be automatically withdrawn from the final program.